Opportunity
SAM #75F40126Q135923
Procurement of Bordetella-Free Baboons for FDA Pertussis Research
Buyer
FDA Office of the Associate General Counsel for Administrative Law
Posted
August 14, 2026
Respond By
August 21, 2026
Identifier
75F40126Q135923
NAICS
112990
The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), Office of Vaccines Research and Review (OVRR), is seeking to procure Bordetella-Free Baboons for pertussis research. - Government Buyer: - U.S. Food and Drug Administration (FDA) - Center for Biologics Evaluation and Research (CBER) - Office of Vaccines Research and Review (OVRR) - Products Requested: - Thirty (30) Bordetella-Free, unvaccinated baboons aged 6-8 months - Delivery in two shipments of 15 animals each to FDA White Oak Campus, Silver Spring, MD - Unique Requirements: - Baboons must be tested negative for Bordetella exposure prior to shipment - Animals must be examined by a licensed veterinarian experienced in Non-Human Primates - Strict health and veterinary standards must be met - OEMs and Vendors: - No specific OEMs or vendors are named; suppliers must provide compliant animals - Notable Details: - Intended for pertussis infection and vaccination studies - Coordination required for two separate shipments - Offers must be held firm through September 30, 2026
Description
See Attached Combined Synopsis/Solicitation 75F40126Q135923